Target doctors for sales
-Sandeep Saxena, CEO and
founder, Acton Biologicals, Pune.
No diagnostics laboratory has a sales team focused on therapeutic
segment. Hence they don’t have any relationships with
doctors, their actual customers. The sales team of diagnostics
laboratories have been meeting pathologists, telling them that we also
do these tests, why don’t you outsource your tests to us.
Doctors shy away from prescribing diagnostics tests and sales are
stunted.
There are lots of tests available in the Indian market, and the doctor
knows about the utility of the test, but is not prescribing that
because there is a communication gap between the company offering it
and the diagnostics lab. The doctor does not have answers to simple
questions such as, what is the sample needed, when will he get the
report, what is the cost, and where should the patient go to drop his
sample. These questions are unanswered, because medical representatives
from diagnostics laboratory have not visited this doctor for many years
now. You cannot blame the medical representative for this as his
mandate is to generate business. It’s more effective and easy
to achieve a sales target by meeting pathologists. The five large
diagnostics companies employ close to 100 people each. It’s
also impossible for these 500 medical representatives to cover all the
seven lakh doctors in India.
There are so many developments happening globally in biochemistry,
radioimmune assay, microbiology, blood tests and genetics. But
pathology labs in India are not able to bring the advancements into
Indian clinical practice as the communication channel is missing. It is
either left to the practicing doctors to read on their own, or the
equipment manufacturers, technology distributors and kit manufacturers
to push their products to the markets.
Most medium to large diagnostics laboratories have a test menu of
1,000–5,000 tests. Each test is needed by different
therapeutic segment for a different reason. In the brief training that
a diagnostic company gives to its medical representatives, it is
impossible to understand all applications, significance, method of test
and sample needed for all the tests.
While on the other hand, pharmaceutical companies usually have 100
member strong sales teams focused on single therapeutic segments.
Diagnostics companies should follow the pharmaceutical model of sales
focusing on specific therapeutic segments. Pharmaceutical companies
spend close to 20 percent of their revenue into sales and marketing
activities as compared to five percent or less invested by diagnostics
companies.
The medical representative needs to be trained in the segment, needs a
printed test menu for that therapeutic segment and has to gradually
build a relationship with the doctors in that particular segment. He
would be able to give meaningful information on various tests,
availability of test, sample pickup, turn around time, method used for
testing and cost. There will be lots of suggestions in terms of new
tests needed, bundling of tests and research projects that will come
from practicing doctors. If implemented quickly, the diagnostics
laboratory can charge a premium. With this premium coming in,
diagnostics laboratories can organize city wide doctor meets, regional
CMEs and annual national conferences. With these efforts, doctors will
be more confident about why a particular test is essential before a
treatment can be selected.
It’s easier said than done. The kind of investment that is
needed to implement this suggestion is gigantic. But we can start
small. Let’s say one small town and one large therapeutic
category. It can be Pune and cardiovascular disorders. There will be
close to 100 doctors in Pune treating cardiac patients. These doctors
will have specific requirements in terms of diagnostics tests. To build
a relationship with all of them, the team needs training, hand holding,
communication material, regular scientific updation and a lot of
patience.
But once the motion is set, sky is the limit. This exercise will
generate a lot of revenue, learning, database of doctors and confidence
in the sales team. This could be replicated across India for
cardiovascular disorders. Second time onwards, it will be faster and
effective. Next step is to conquer other specialities one by one.